Back to search
Skin Toxicity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Toxicity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Toxicity trials you may qualify forThis is a multicenter, prospective, non-randomized, open-label, pharmacokinetic study, aiming to compare the plasma exposure of the payload (free-DXd) in patien…
This study is a multicenter randomized controlled trial designed to evaluate the effectiveness of a structured telenursing intervention in patients with breast…
This study evaluates the capacity of the NovaGray RILA Breast® test to predict the toxicity linked to radiotherapy and the impact of implant breast reconstructi…
The goal of this clinical trial is to learn about HT-001 Topical Gel for treatment of EGFR inhibitor-induced skin toxicities. The main questions it aims to answ…
This study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in sit…
The purpose of this research is to study a Chinese herbal Complementary and Alternative Medicine (CAM) product for the temporary relief of pain and itching afte…
The goal of this clinical research study is to find the recommended dose level and recommended number of injections of the study agent DNX-2401 that can be give…
ATOPE-PRO, was developed with the intention of consolidating the integration of an innovative system for the prevention of cancer therapy-related cardiovascular…